Oxidative stress in Helicobacter pylori infection: does supplementation with vitamins C and E increase the eradication rate
The Afternoon Athlete: You finish a grueling CrossFit session or a 5-mile run
The results add to a series of positive late-stage trial reveals for orforglipron, including the recent ATTAIN-1 and ATTAIN-2 trials, which showed average weight loss of up to 12.4% and 10.5%, respectively, in overweight people with and without diabetes
In physician-supervised protocols, the oral route makes it particularly applicable for leaky gut, IBS, post-surgical GI recovery, and gut-related inflammatory conditions
They are coming off the Category 2 restricted list effective April 23, 2026, with PCAC review of their compounding eligibility scheduled for July 23-24, 2026